您的购物车当前为空
AGN 192836 is a potent and selective α2 adrenergic agonist (EC50s: 8.7, 41 and 6.6 nM for α2A, α2B and α2C receptor).
AGN 192836 is a potent and selective α2 adrenergic agonist (EC50s: 8.7, 41 and 6.6 nM for α2A, α2B and α2C receptor).

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 2,480 | 5日内发货 | |
| 25 mg | ¥ 10,700 | 8-10周 | |
| 50 mg | ¥ 14,000 | 8-10周 | |
| 100 mg | ¥ 21,800 | 8-10周 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,180 | 5日内发货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
该分子属于定制产品。TargetMol拥有优秀的合成团队,经验和能力,可以为您提供高性价比的产品。 但由于客观因素,研发中会存在小概率合成不成功的情况,还请理解。 如您有任何问题,欢迎咨询,我们将竭诚为您服务。
| 产品描述 | AGN 192836 is a potent and selective α2 adrenergic agonist (EC50s: 8.7, 41 and 6.6 nM for α2A, α2B and α2C receptor). |
| 靶点活性 | α2C-adrenoceptor: 6.6 nM , α2A-adrenoceptor:(EC50)8.7 nM , α2B-adrenoceptor: 41 nM |
| 体外活性 | AGN 192836 is 1200-fold selective for the α2A-receptor relative to the α1-receptor, 50-fold selective for the α2A-receptor relative to the α2B-receptor, and 10-fold selective for the α2Areceptor relative to the α2C-receptor. |
| 体内活性 | AGN 192836 is equally efficacious when compared to brimonidine for the reduction of intraocular pressure upon topical administration to the rabbit and more efficacious than brimonidine for the reduction of blood pressure upon intravenous administration to monkey. |
| 分子量 | 231.25 |
| 分子式 | C12H13N3O2 |
| CAS No. | 171102-29-7 |
| Smiles | Cc1c(Nc2ncc[nH]2)ccc2OCCOc12 |
| 密度 | 1.342 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多